from forming that could re-clog a treated artery. They have largely been replaced by newer models, such as Abbott Laboratories Xience, co-marketed as Promus by Boston Scientific. Virmani and her colleagues found fractures in 51 of the 177 treated...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Broken heart stents may be more common than thought
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account